A detailed history of Howland Capital Management LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Howland Capital Management LLC holds 29,180 shares of EW stock, worth $1.98 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
29,180
Previous 29,180 -0.0%
Holding current value
$1.98 Million
Previous $2.7 Million 28.57%
% of portfolio
0.09%
Previous 0.13%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$84.3 - $94.31 $29,505 - $33,008
-350 Reduced 1.19%
29,180 $2.7 Million
Q3 2023

Oct 17, 2023

SELL
$69.28 - $93.38 $5,542 - $7,470
-80 Reduced 0.27%
29,530 $2.05 Million
Q3 2022

Oct 17, 2022

BUY
$82.37 - $107.29 $1.34 Million - $1.75 Million
16,300 Added 122.46%
29,610 $2.45 Million
Q4 2021

Jan 26, 2022

BUY
$106.37 - $130.68 $6,382 - $7,840
60 Added 0.45%
13,310 $1.72 Million
Q3 2021

Oct 25, 2021

SELL
$102.91 - $122.75 $12,863 - $15,343
-125 Reduced 0.93%
13,250 $1.5 Million
Q1 2021

Apr 28, 2021

SELL
$78.68 - $90.67 $66,248 - $76,344
-842 Reduced 5.92%
13,375 $1.12 Million
Q4 2020

Jan 26, 2021

SELL
$71.69 - $91.23 $14,266 - $18,154
-199 Reduced 1.38%
14,217 $1.3 Million
Q3 2020

Oct 26, 2020

SELL
$67.19 - $87.44 $221,727 - $288,552
-3,300 Reduced 18.63%
14,416 $1.15 Million
Q2 2020

Jul 15, 2020

BUY
$57.54 - $76.95 $647,612 - $866,072
11,255 Added 174.2%
17,716 $1.22 Million
Q1 2020

Apr 13, 2020

SELL
$52.41 - $81.0 $48,741 - $75,330
-930 Reduced 12.58%
6,461 $406,000
Q4 2019

Jan 23, 2020

SELL
$71.7 - $82.09 $8,604 - $9,850
-120 Reduced 1.6%
7,391 $1.72 Million
Q1 2019

Apr 22, 2019

BUY
$47.89 - $64.05 $9,146 - $12,233
191 Added 2.61%
7,511 $1.44 Million
Q1 2018

May 02, 2018

BUY
$37.19 - $47.45 $12,384 - $15,800
333 Added 4.77%
7,320 $1.02 Million
Q3 2017

Oct 30, 2017

BUY
$36.29 - $38.83 $253,558 - $271,305
6,987
6,987 $764,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Howland Capital Management LLC Portfolio

Follow Howland Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Howland Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Howland Capital Management LLC with notifications on news.